Research-grade products carry real risks around purity, sterility, dosing accuracy, and labeling
While the exact mechanism is not fully understood, clinical data consistently shows lower nausea rates with tirzepatide (25-33%) compared to semaglutide (44%) despite greater overall weight loss
MJD is co-funded by the NIHR Leicester Biomedical Research Centre and University of Leicester
A: As an experimental compound, side effects are documented within clinical trial reports
The appetite suppression timeline varies significantly between individuals, and this phase is about building a foundation, not seeing dramatic results
90 A recent clinical trial assessing the histological benefits of tirzepatide for MASH reported that tirzepatide 5 mg achieved at least one-stage improvement in fibrosis for 55% of patients without worsening MASH, and 43.6% of patients experienced MASH resolution with no worsening fibrosis